Micronucleus assays with the human derived liver cell line (Huh6): A promising approach to reduce the use of laboratory animals in genetic toxicology.


Journal

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
ISSN: 1873-6351
Titre abrégé: Food Chem Toxicol
Pays: England
ID NLM: 8207483

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 08 04 2021
revised: 11 06 2021
accepted: 13 06 2021
pubmed: 21 6 2021
medline: 3 11 2021
entrez: 20 6 2021
Statut: ppublish

Résumé

The inadequate representation of enzymes which catalyze the activation/detoxification of xenobiotics in cells that are currently used in genotoxicity testing of chemicals leads to a high number of false positive results and the number of follow up studies with rodents could be reduced by use of more reliable in vitro models. We found earlier that several xenobiotic drug metabolizing enzymes are represented in the human derived liver cell line Huh6 and developed a protocol for micronucleus (MN) experiments which is in agreement with the current OECD guideline. This protocol was used to test 23 genotoxic and non-genotoxic reference chemicals; based on these results and of earlier findings (with 9 chemicals) we calculated the predictive value of the assay for the detection of genotoxic carcinogens. We found a sensitivity of 80% and a specificity of 94% for a total number of 32 chemicals; comparisons with results obtained with other in vitro assays show that the validity of MN tests with Huh6 is higher as that of other experimental models. These results are promising and indicate that the use of Huh6 cells in genetic toxicology may contribute to the reduction of the use of laboratory rodents; further experimental work to confirm this assumption is warranted.

Identifiants

pubmed: 34147571
pii: S0278-6915(21)00388-4
doi: 10.1016/j.fct.2021.112355
pii:
doi:

Substances chimiques

Carcinogens 0
Mutagens 0

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

112355

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Miroslav Mišík (M)

Institute of Cancer Research, Medical University of Vienna, Vienna, Austria.

Armen Nersesyan (A)

Institute of Cancer Research, Medical University of Vienna, Vienna, Austria.

Michael Kment (M)

Institute of Cancer Research, Medical University of Vienna, Vienna, Austria.

Benjamin Ernst (B)

Institute of Cancer Research, Medical University of Vienna, Vienna, Austria.

Tahereh Setayesh (T)

Institute of Cancer Research, Medical University of Vienna, Vienna, Austria.

Franziska Ferk (F)

Institute of Cancer Research, Medical University of Vienna, Vienna, Austria.

Klaus Holzmann (K)

Institute of Cancer Research, Medical University of Vienna, Vienna, Austria.

Georg Krupitza (G)

Department of Pathology, Medical University of Vienna, Vienna, 1090, Austria.

Siegfried Knasmueller (S)

Institute of Cancer Research, Medical University of Vienna, Vienna, Austria. Electronic address: siegfried.knasmueller@meduniwien.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH